Lexicon Pharmaceuticals | Spese Operative

Prezzo Delle Azioni
1.32
Cambio Giornaliero
0.01 0.38%
Mensile
11.44%
Annuale
89.21%
Q1 Previsione
2.01




Spese Operative Cambiamento Data
Abbott USD 9.21B 17M 2025-12
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Agios Pharmaceuticals USD 129.75M 9.76M 2025-09
Akebia Therapeutics USD 43.82M 16.98M 2025-03
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
AstraZeneca USD 12.53B 4.16B 2025-12
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Coherus Biosciences USD 53.03M 43.41M 2025-03
Eli Lilly USD 10.31B 1.09B 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Halozyme Therapeutics USD 136.34M 13.06M 2025-09
Illumina USD 903M 69M 2025-12
Insmed USD 403.69M 42.4M 2025-09
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 18.97B 2.38B 2025-12
Lexicon Pharmaceuticals USD 57M 10.54M 2024-06
MacroGenics USD 67M 8M 2025-09
MannKind USD 63.35M 2.51M 2025-09
Merck USD 10.16B 558M 2025-12
Moderna USD 1.28B 232M 2025-09
Novartis USD 9.86B 115M 2025-09
PTC Therapeutics USD 207.52M 6.21M 2025-09
Puma Biotechnology USD 49.26M 3.2M 2024-06
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
United Therapeutics USD 6.59B 6.07B 2025-09
Vanda Pharmaceuticals USD 466M 20.33M 2025-09


Lexicon Pharmaceuticals Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.